Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 13,865,000 | 12,225,000 | 15,121,000 | 14,812,000 | 14,583,000 |
| Cost of Goods | 4,240,000 | 3,986,000 | 4,170,000 | 5,022,000 | 4,170,000 |
| Gross Profit | 9,625,000 | 8,239,000 | 10,951,000 | 9,790,000 | 10,413,000 |
| Operating Expenses | 5,112,000 | 5,471,000 | 5,449,000 | 5,187,000 | 7,118,000 |
| Operating Income | 4,513,000 | 2,768,000 | 5,502,000 | 4,603,000 | 3,295,000 |
| Interest Expense | 552,000 | 553,000 | 566,000 | 560,000 | 556,000 |
| Other Income | -1,351,000 | -1,740,000 | -1,971,000 | 357,000 | -1,556,000 |
| Pre-tax Income | 2,610,000 | 475,000 | 2,965,000 | 4,400,000 | 1,183,000 |
| Income Tax | 583,000 | 234,000 | 493,000 | 448,000 | 255,000 |
| Net Income Continuous | 2,027,000 | 241,000 | 2,472,000 | 3,952,000 | 928,000 |
| Minority Interests | -3,000 | -2,000 | 1,000 | -3,000 | -4,000 |
| Net Income | $2,024,000 | $239,000 | $2,473,000 | $3,949,000 | $924,000 |
| EPS Basic Total Ops | 0.12 | 0.01 | 0.15 | 0.23 | 0.06 |
| EPS Basic Continuous Ops | 0.12 | 0.01 | 0.15 | 0.23 | 0.06 |
| EPS Diluted Total Ops | 0.12 | 0.01 | 0.15 | 0.23 | 0.05 |
| EPS Diluted Continuous Ops | 0.12 | 0.01 | 0.15 | 0.23 | 0.05 |
| EBITDA(a) | $5,422,000 | $3,155,000 | $5,688,000 | $7,165,000 | $3,791,000 |